Friday, October 24, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Bitcoin

S&P 500 Snub Deals Major Blow to MicroStrategy’s Bitcoin Ambitions

Robert Sasse by Robert Sasse
September 6, 2025
in Bitcoin, Blockchain, Crypto Stocks, S&P 500
0
Strategy Stock
0
SHARES
127
VIEWS
Share on FacebookShare on Twitter

In a move that stunned market participants, the committee overseeing the S&P Dow Jones Indices rejected MicroStrategy’s inclusion in the benchmark index this past Friday. The business intelligence firm, which recently rebranded as Strategy Inc., was passed over despite meeting all formal technical requirements for admission, including sufficient market capitalization and four consecutive profitable quarters. Instead, the coveted spots were awarded to Robinhood, AppLovin, and Emcor Group.

This exclusion represents a significant setback for the company. Inclusion would have compelled index-tracking funds to purchase its stock, and market experts had projected potential inflows of approximately $16 billion. The disappointment triggered an immediate sell-off, sending the company’s shares tumbling in after-hours trading.

A High-Stakes Strategy Faces Scrutiny

The decision is widely interpreted as a pointed critique of MicroStrategy’s singular focus. While the traditional financial market shows it a cold shoulder, the company continues to aggressively pursue its Bitcoin acquisition strategy. It now holds a colossal 214,400 Bitcoin, a stash valued at over $70 billion and the largest of any publicly traded corporation worldwide.

Should investors sell immediately? Or is it worth buying Strategy?

However, this massive expansion has come at a considerable cost. To fund its relentless Bitcoin purchases, MicroStrategy has systematically diluted existing shareholders through substantial secondary stock offerings. The company recently broke its own promise not to sell shares below a specific valuation multiple, underscoring the immense pressure to continue funding its crypto acquisitions.

Growing Disconnect Between Assets and Valuation

A particularly troubling trend for investors is the growing divergence between the company’s Bitcoin holdings and its stock performance. Although the Bitcoin treasury has more than doubled since the stock’s peak in late 2024, the share price has failed to keep pace. Consequently, each share now represents a significantly larger underlying Bitcoin value, a fact the market has so far refused to reward appropriately.

The S&P committee’s verdict appears to signal deep institutional skepticism regarding the sustainability of MicroStrategy’s high-risk, crypto-centric business model. The subsequent downward trend in the stock price following the news highlights a critical moment of reassessment for the pioneering Bitcoin corporate holder.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from October 24 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 24.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Bitcoin Stock
Bitcoin

Bitcoin’s Calm Consolidation Masks Significant Accumulation

October 24, 2025
Riot Blockchain Stock
AI & Quantum Computing

Riot Blockchain’s Strategic Pivot to AI Computing Captivates Market

October 24, 2025
Canaan Stock
Blockchain

Canaan Stock Surges on Major Order and Operational Milestones

October 24, 2025
Next Post
Eli Lilly Stock

Lilly's Oncology Breakthrough: Cancer Drug Designation Signals Pipeline Strength

OceanFirst Stock

OceanFirst's Strategic Moves Amid Mixed Financial Performance

US Physical Therapy Stock

Mixed Signals Emerge as US Physical Therapy Posts Record Results Amid Insider Sales

Recommended

Allied Motion Stock

Allied Motion Posts Record Profit Margins and Soaring Earnings

2 months ago
Biotechnology Stock Exchange

Analysts Bullish on Alpine Immune Sciences Price Targets and Ratings Upgraded

2 years ago
AutoZone Stock

AutoZone Earnings Preview: High Expectations Set the Stage

1 month ago
Finance_ Chart Down

Analyst Adjusts Price Target for MVB Financial Diverse Opinions in the Financial Industry

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Can Puma’s Radical Overhaul Reverse Its Downward Spiral?

Bitcoin’s Calm Consolidation Masks Significant Accumulation

Cellectar Biosciences at a Critical Juncture: Regulatory and Financial Developments Converge

Super Micro Stock Plummets After Stunning Forecast Downgrade

3M Shares Surge on Strong Quarterly Performance and Upbeat Forecast

High-Yield Gamble: The Oxford Square Capital Investment Dilemma

Trending

BASF Stock
Analysis

A Tale of Two Titans: Comparing Investment Strategies in Germany’s Chemical Sector

by Dieter Jaworski
October 24, 2025
0

Within Germany's prestigious chemical industry, two distinct competitors present investors with fundamentally different value propositions. On one...

Novo Nordisk Stock

Leadership Shakeup at Novo Nordisk Sparks Investor Uncertainty

October 24, 2025
CureVac Stock

CureVac Acquisition Enters Final Phase as BioNTech Makes Formal Bid

October 24, 2025
Puma Stock

Can Puma’s Radical Overhaul Reverse Its Downward Spiral?

October 24, 2025
Bitcoin Stock

Bitcoin’s Calm Consolidation Masks Significant Accumulation

October 24, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • A Tale of Two Titans: Comparing Investment Strategies in Germany’s Chemical Sector
  • Leadership Shakeup at Novo Nordisk Sparks Investor Uncertainty
  • CureVac Acquisition Enters Final Phase as BioNTech Makes Formal Bid

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com